Progranulin inhibits LPS-induced macrophage M1 polarization via NF-kB and MAPK pathways

被引:195
|
作者
Liu, Lianlian [1 ,2 ,3 ]
Guo, Hongmei [1 ]
Song, Aimei [1 ,2 ,3 ]
Huang, Jiahui [1 ]
Zhang, Yu [1 ]
Jin, Shanshan [1 ]
Li, Shutong [1 ]
Zhang, Liguo [1 ]
Yang, Chengzhe [4 ,5 ]
Yang, Pishan [1 ,2 ,3 ]
机构
[1] Shandong Univ, Dept Periodontol, Sch Stomatol, 44 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China
[2] Shandong Prov Key Lab Oral Tissue Regenerat, Jinan, Shandong, Peoples R China
[3] Shandong Engn Lab Dent Mat & Oral Tissue Regenera, Jinan, Shandong, Peoples R China
[4] Shandong Univ, Dept Oral & Maxillofacial Surg, Qilu Hosp, Jinan 250012, Shandong, Peoples R China
[5] Shandong Univ, Inst Stomatol, Jinan 250012, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
PGRN; Macrophage polarization; NF-kappa B; MAPK; Lipopolysaccharide (LPS); KAPPA-B; TNF; LIPOPOLYSACCHARIDE; PERIODONTITIS; ACTIVATION; ANTIBODIES;
D O I
10.1186/s12865-020-00355-y
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Macrophage M1 polarization plays a pivotal role in inflammatory diseases. Progranulin (PGRN) has potential anti-inflammation action, however, the effect of PGRN on macrophage M1 polarization has been poorly studied. Our study aimed to investigate the effect of PGRN on lipopolysaccharide (LPS)-induced macrophage M1 polarization and clarify the underlying mechanisms. Methods RAW264.7 cells were polarized to M1 macrophage by LPS with or without recombinant PGRN (rPGRN) and tumor necrosis factor alpha antibody (anti-TNF-alpha). A cell counting kit-8 assay (CCK-8), flow cytometry, Quantitative Real-Time PCR assay (q-PCR), Western blot assay and enzyme-linked immunosorbent assay (ELISA) were used to determine the effect of different treatments on cell proliferation, expression of surface phenotype marker and expressions and secretion of inflammatory cytokines. The activation of NF-kappa B/mitogen-activated protein kinase (MAPK) pathways and the nuclear translocation of NF-kappa B p65 were detected by Western blot and immunofluorescence respectively. THP-1 and primary bone marrow-derived monocytes (BMDMs) were also used to demonstrate effect of PGRN on expressions and secretion of inflammatory cytokines induced by LPS. Results In RAW264.7 cells, rPGRN at concentrations below 80 ng/ml significantly promoted cell proliferation in dose dependent fashion. rPGRN significantly inhibited LPS-induced change of phenotype (CD86/CD206 ratio) and function (tumor necrosis factor (TNF-alpha) and inducible nitric oxide synthase (iNOS) expressions). LPS-stimulated secretion of TNF-alpha and activated phosphorylation of IKK alpha/beta, IkB alpha, p65, JNK and p38 and the nucleus translocation of NF-kB p65 were also significantly downregulated by rPGRN. In addition, recombinant TNF-alpha (rTNF-alpha) significantly boosted TNF-alpha and iNOS expression vs the control group. Moreover, anti-TNF-alpha significantly inhibited LPS-induced TNF-alpha and iNOS expression. In THP-1 and BMDM cells, reversing effect of rPGRN on LPS-enhanced expressions of TNF-alpha and iNOS and secretion of TNF-alpha was further demonstrated. Conclusions PGRN down-regulates LPS-induced macrophage M1 polarization in phenotype and function via NF-kappa B/MAPK signaling pathways.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways
    Lianlian Liu
    Hongmei Guo
    Aimei Song
    Jiahui Huang
    Yu Zhang
    Shanshan Jin
    Shutong Li
    Liguo Zhang
    Chengzhe Yang
    Pishan Yang
    BMC Immunology, 21
  • [2] Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways
    Lai, Jin-lun
    Liu, Yu-hui
    Liu, Chang
    Qi, Ming-pu
    Liu, Rui-ning
    Zhu, Xi-fang
    Zhou, Qiu-ge
    Chen, Ying-yu
    Guo, Ai-zhen
    Hu, Chang-min
    INFLAMMATION, 2017, 40 (01) : 1 - 12
  • [3] Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways
    Jin-lun Lai
    Yu-hui Liu
    Chang Liu
    Ming-pu Qi
    Rui-ning Liu
    Xi-fang Zhu
    Qiu-ge Zhou
    Ying-yu Chen
    Ai-zhen Guo
    Chang-min Hu
    Inflammation, 2017, 40 : 1 - 12
  • [4] Decursinol Angelate Inhibits LPS-Induced Macrophage Polarization through Modulation of the NFκB and MAPK Signaling Pathways
    Ul Islam, Salman
    Lee, Jung Ho
    Shehzad, Adeeb
    Ahn, Eun-Mi
    Lee, You Mie
    Lee, Young Sup
    MOLECULES, 2018, 23 (08):
  • [5] Urolithin B inhibits LPS-induced macrophage M1 polarization via miR155-5p mediated MAPK/NF-кB pathway
    Tuohudaali, Wulipan
    Ji, Teng-Fei
    Ding, Wan-Ting
    Li, Chen-Yang
    Bianba, Jian-Shen
    Ci, Ren
    Zhao, Jun
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2024,
  • [6] Loliolide, isolated from Sargassum horneri; abate LPS-induced inflammation via TLR mediated NF-KB, MAPK pathways in macrophages
    Jayawardena, Thilina U.
    Kim, Hyun-Soo
    Sanjeewa, K. K. Asanka
    Han, Eui Joeng
    Jee, Youngheun
    Ahn, Ginnae
    Rho, Jung-Rae
    Jeon, You-Jin
    ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS, 2021, 56
  • [7] THE STREPTOCOCCUS PNEUMONIAE CAPSULE INHIBITS MACROPHAGE ACTIVATION THROUGH THE NF-KB AND NOT MAPK ACTIVATION PATHWAYS
    Hyams, C. J.
    Camberlein, E.
    Noursadeghi, M.
    Weiser, J. N.
    Brown, J. S.
    THORAX, 2009, 64 : A36 - A36
  • [8] Isobavachalcone prevents osteoporosis by suppressing activation of ERK and NF-KB pathways and M1 polarization of macrophages
    Wang, Xiangyu
    Ji, Quanbo
    Hu, Wenhao
    Zhang, Zhifa
    Hu, Fanqi
    Cao, Shiqi
    Wang, Qi
    Hao, Yongyu
    Gao, Meng
    Zhang, Xuesong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 94
  • [9] Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
    Cunha, Carolina
    Gomes, Catia
    Vaz, Ana Rita
    Brites, Dora
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [10] SENP1-KLF4 signalling regulates LPS-induced macrophage M1 polarization
    Wang, Kezhou
    Xiong, Jie
    Lu, Yiwen
    Wang, Lifeng
    Tian, Tian
    FEBS JOURNAL, 2023, 290 (01) : 209 - 224